Stress Ulcer Prophylaxis with PPIs vs H2RBs, Polygenic Risk Scores for Predicting CVD, HMG-CoA Reductase Inhibition and Ovarian Cancer, and more

Published: Feb. 18, 2020, 4 p.m.

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the February 18, 2020 issue